In Burkitt’s lymphoma (Daudi) and leukemia cells, loss of RB1 function appears to be reversible, and IFN-β signaling induces RB1 gene expression or restores RB1 function by reducing its phosphorylation (23–30). This evidence concerns the gene RB1 and Burkitt lymphoma.